Abstract
Get full access to this article
View all access options for this article.
References
1.FDA drug safety communication : FDA revises warnings regarding use of the diabetes medicine metformin in certain patients with reduced kidney function . https://www.fda.gov/Drugs/DrugSafety/ucm493244.htm. Accessed January 11, 2017 .
2.Metformin-containing drugs : drug safety communication—revised warnings for certain patients with reduced kidney function . http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm494829.htm. Accessed January 11, 2017 .
3.KDIGO 2012 clinical practice guidelines for the evaluation and management of chronic kidney disease . http://www.kdigo.org/clinical_practice_guidelines/pdf/CKD/KDIGO_2012_CKD_GL.pdf. Accessed March 7, 2017 .